BIOTECH FIRM GENEXINE VACCINE READY FOR CLINICAL TESTING – COVID-19

Highlights –

• South Korea’s first potential vaccine is ready for clinical testing.
• Biotech firm Genexine has developed the potential vaccine.
• GX-19 is the name of the vaccine.
• The firm will apply for clinical testing of GX-19 within May.

South Korean biotech firm Genexine’s COVID-19 deoxyribonucleic acid vaccine pipeline GX-19 is ready for c....